SEARCH
Enter your search term below:
INSIGHTS / News
University spin-out “Azellon” announces recruitment phase of knee repair clinical trial
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close 
Mailing List sign-up
LATEST
TWEETS
To mark #IWD2021 @SETsquared_Br has opened applications for #EnterprisingWomen 2.0 See below for more info on th… twitter.com/i/web/status/13689…
Here at SETsquared we champion women in tech & encourage female founders at all stages of their business journey t… twitter.com/i/web/status/13689…“My advice to women who are thinking of starting a tech business is - if you see an opportunity or solution & are p… twitter.com/i/web/status/13689…
️When do we #ChooseToChallenge? SETsquared #healthtech trailblazer Dr Chen Davies saw her innovation @LatchAid bor… twitter.com/i/web/status/13689…
Next, we celebrate @SETsquaredSRY's Healthtech trailblazer @Fiona_Sweny - a budding female founder who saw a need… twitter.com/i/web/status/13689…
